Clinical Trial Update: Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing radiodynamic therapy with Gliolan (5-ALA) for first recurrence glioblastoma, currently recruiting in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Gliolan (5-aminolevulinic acid)

Snippet

Sponsor: Universität Münster | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING